Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI)

Critical Care Medicine
David MairTed Eastlund

Abstract

Discuss the pros and cons of using donor and blood product-management strategies to prevent transfusion-related acute lung injury (TRALI). A review of the literature was performed. Despite therapeutic advances in pulmonary and critical care medicine, TRALI is now considered to be one of the leading causes of transfusion-associated mortality, and thus determining how to prevent TRALI is extremely important. Donor and product-management strategies to prevent this life-threatening condition have been suggested, but because of gaps in our understanding of TRALI, blood-bankers do not know how beneficial these interventions will be, nor the amount of potential harm-such as decreasing the availability of blood-that could arise if they were implemented. This article discusses the advantages and disadvantages of the various preventive measures that have been described in the literature. Preventing TRALI poses a difficult challenge for blood-banking experts, because it is unknown which measures will be effective in decreasing the incidence of TRALI and which could have significant drawbacks. Only additional research into TRALI prevention will provide the answers on how to best protect patients from this potentially fatal reaction.

References

Jan 1, 1991·Acta Haematologica·C ElbertD Cordle
Jun 1, 1990·Transfusion·G Sirchia, A Zanella
Jul 1, 1983·The American Review of Respiratory Disease·M A PopovskyS B Moore
Jan 27, 1999·Transfusion·T L DensmoreH Chaplin
Jul 30, 1999·Transfusion Medicine Reviews·C C Silliman
Mar 10, 2001·Transfusion·A RizkR Weinstein
Oct 19, 2001·Transfusion·P M KopkoP V Holland
Nov 29, 2001·Transfusion·N WinG Lucas
Mar 21, 2002·Vox Sanguinis·C P EngelfrietB Zupańska
Apr 19, 2002·JAMA : the Journal of the American Medical Association·Patricia M KopkoMark A Popovsky
Dec 11, 2002·Transfusion Medicine·N WinG Lucas
Apr 19, 2003·Transfusion·Christopher C SillimanNorbert F Voelkel
Sep 1, 1957·Vox Sanguinis·T E BRITTINGHAM
Oct 23, 2003·Transfusion Medicine Reviews·L Ross Pierce, Nisha Jain
Oct 23, 2003·Transfusion Medicine Reviews·Kathryn E Webert, Morris A Blajchman
Apr 6, 2004·Clinics in Chest Medicine·Patricia M Kopko, Mark A Popovsky
Apr 29, 2004·Transfusion Medicine·A InsunzaV Hermosa
Jul 13, 2004·Transfusion Medicine Reviews·Leslie HolnessPeter A Lachenbruch
Oct 30, 2004·The Journal of Medicine and Philosophy·David B Resnik
Dec 23, 2004·Archives of Disease in Childhood·D R NorfolkS Kinsey
Apr 9, 2005·Critical Care Medicine·Pearl ToyUNKNOWN National Heart, Lung and Blood Institute Working Group on TRALI
Apr 15, 2005·Transfusion Medicine Reviews·Mindy GoldmanUNKNOWN TRALI Consensus Panel
Jun 11, 2005·Mayo Clinic Proceedings·Ognjen Gajic, S Breanndan Moore
Sep 27, 2005·Transfusion·Ulrich J H SachsGregor Bein

❮ Previous
Next ❯

Citations

Sep 4, 2012·The International Journal of Angiology : Official Publication of the International College of Angiology, Inc·Vijay A Singh, David Zeltsman
Jun 9, 2010·Expert Review of Respiratory Medicine·Mladen Sokolovic, Stephen M Pastores
May 5, 2009·AACN Advanced Critical Care·Elizabeth A Katz
Feb 4, 2010·Journal of Clinical Anesthesia·Annette SchmidtHendrik W Gervais
Feb 17, 2010·Medicina intensiva·J M AñónM J Bruscas
Jun 4, 2008·Critical Care Medicine·Mark R Looney
Feb 3, 2009·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Anne Federico
Nov 11, 2008·Biochimica Et Biophysica Acta·Caroline P Ozment, Jennifer L Turi
Jul 30, 2008·Journal of Cardiothoracic and Vascular Anesthesia·Praveen Kumar NeemaMohammed M Minhaj
Oct 9, 2007·Obstetrics and Gynecology Clinics of North America·Andrea J Fuller, Brenda Bucklin
Aug 12, 2009·British Journal of Haematology·Alexander B BensonChristopher C Silliman
Mar 29, 2008·Journal of Intensive Care Medicine·Randeep S JawaMahmoud N Kulaylat
Feb 10, 2010·Clinical Obstetrics and Gynecology·Andrea J Fuller, Brenda A Bucklin
Dec 20, 2007·Dimensions of Critical Care Nursing : DCCN·Carol A Dennison
Sep 4, 2021·ERJ Open Research·Akira YokoyamaTakahide Nagase

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.